Articles, guides, and regulatory updates from our community.
New research reveals how thymosin alpha 1 immune modulation may help combat HIV latency through IL-15 pathway activation in laboratory studies.
By Peptide Association Research Team
New research reveals thymosin alpha 1 immune therapy combined with IL-15 may help reverse immune cell aging in hepatocellular carcinoma. Learn the implications.
By Peptide Association Research Team
New 2026 research explores thymosin alpha 1 immune effects on CD8 T cells. Learn what this study means for immune peptide therapy applications.
By Peptide Association Research Team
New research on SS-31 Elamipretide and NAC shows promising airway protection mechanisms. Learn implications for thymosin alpha 1 immune support therapy.
By Peptide Association Research Team
Breakthrough study reveals how natural compounds protect against cognitive decline through anti-inflammatory pathways. Learn implications for peptide therapy.
By Peptide Association Research Team
New research reveals stable peptide formulation methods for glatiramer acetate nanoparticles, advancing peptide therapy manufacturing and storage solutions.
By Peptide Association Research Team
Groundbreaking research reveals next-generation GLP-1 peptide therapies targeting multiple receptors for enhanced diabetes and obesity treatment outcomes.
By Peptide Association Research Team
New research reveals how MAPK p38α inhibition overcomes FPR1 mutations affecting immune surveillance. Learn about peptide therapy implications.
By Peptide Association Research Team
Recent study reveals diammonium glycyrrhizinate and vitamin D3 combination may help treat pulmonary fibrosis through novel mechanisms. Learn about the research.
By Peptide Association Research Team
New FDA study reveals higher adverse events in compounded GLP-1 peptides vs commercial versions. Important safety insights for peptide therapy providers.
By Peptide Association Research Team